Twig
EMEA
London
,
United Kingdom
Startup
FOUNDED
2022
HEADCOUNT
2-20
FUNDING
Seed
Keywords:
bacteria, AI/ML, metabolic_engineering, precision_fermentation, laboratory_automation, HTP_screening, hydrocolloids
BUSINESS
Twig Bio uses AI-driven strain design (bio:drive) and automated high-throughput lab robotics (grow:bot) to engineer microbial strains that produce sustainable replacements for consumer goods ingredients currently sourced from fossil fuels, animals, or intensive agriculture. Initial targets include hyaluronic acid and isoprene. The company licenses production-ready strains rather than manufacturing ingredients itself.
BIOTECH INVOLVEMENT
Twig Bio engineers bacterial strains using AI/ML-guided design to produce target molecules via fermentation. The platform processes tens of thousands of strain variants per week through automated lab workflows, with every experiment feeding transfer learning models that direct the next round of design.
TECHNOLOGY PLATFORM
AI strain design (bio:drive); automated wet lab (grow:bot); precision fermentation
PRIMARY PRODUCTS
bioengineered alternatives (e.g., to hyaluronic acid and isoprene)